Minute Insight: ConvaTec Enters Wound Biologics Market By Acquiring Triad
Executive Summary
ConvaTec will pay $125m upfront for Memphis-based Triad, plus up to $50m in short-term milestone payments and up to $275m more contingent on Triad’s financial performance over the next two years.